1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Translocation-associated Soft Tissue Sarcoma: new trials by email Literature Review of Translocation-associated Soft Tissue Sarcoma trials Research Report on Translocation-associated Soft Tissue Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma Biospecimen Collection, Computed Tomography, Echocardiography - Metastatic Leiomyosarcoma, Unresectable Leiomyosarcoma | Phase 2 | Recruiting | Northwestern University | 73 | 2024-09-19 | 2026-10-13 |
Bone Neoplasms (1) · Leiomyosarcoma (1) · Osteosarcoma (1) · Sarcoma, Ewing (1) · Sarcoma, Synovial (1)
Bone Diseases (1) · Musculoskeletal Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Bone Tissue (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Muscle Tissue (1) · Sarcoma (1)
United States (1)
Pedro Hermida de Viveiros, MD (1)
P30CA060553 (1)